Call 520-222-5425 or schedule a consultation
At doses of 7 mg and 14 mg per day, it is approved as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes, and to reduce the risk of major adverse cardiovascular events in adults with that condition who are at high cardiovascular risk
Targeted Fat Reduction: This treatment is ideal for those who struggle with fat pockets that are resistant to diet and exercise, such as under the chin, thighs, abdomen, and flanks
However, people with MS who also have obesity or type 2 diabetes may be candidates for GLP-1 therapy, says Alan David Kaye, MD, PhD, a professor and the vice chair of research in the anesthesiology department at LSU Health in Shreveport, Louisiana
Always consult a licensed healthcare provider before beginning any new injection, infusion or supplement routine